89 related articles for article (PubMed ID: 11384536)
1. Candida dubliniensis candidemia in Australia.
Marriott D; Laxton M; Harkness J
Emerg Infect Dis; 2001; 7(3):479. PubMed ID: 11384536
[No Abstract] [Full Text] [Related]
2. Candidemia in patients with ventricular assist devices.
Shoham S; Shaffer R; Sweet L; Cooke R; Donegan N; Boyce S
Clin Infect Dis; 2007 Jan; 44(2):e9-12. PubMed ID: 17173211
[TBL] [Abstract][Full Text] [Related]
3. Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Cancelas JA; Lopez J; Cabezudo E; Navas E; Garcia Laraña J; Jimenez Mena M; Diz P; Perez de Oteyza J; Villalon L; Sanchez-Sousa A
Bone Marrow Transplant; 1994 Mar; 13(3):333-4. PubMed ID: 8199575
[TBL] [Abstract][Full Text] [Related]
4. Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single center.
Vigouroux S; Morin O; Moreau P; Harousseau JL; Milpied N
Haematologica; 2006 May; 91(5):717-8. PubMed ID: 16670081
[TBL] [Abstract][Full Text] [Related]
5. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
[TBL] [Abstract][Full Text] [Related]
6. Candida guilliermondii fungemia. To treat or not to treat.
Manzar S
Saudi Med J; 2004 Jan; 25(1):115. PubMed ID: 14758396
[No Abstract] [Full Text] [Related]
7. Risk factors for breakthrough candidemia.
Nucci M; Colombo AL
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):209-11. PubMed ID: 11957023
[TBL] [Abstract][Full Text] [Related]
8. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Thomas F; Mebtouche B; Clavier H; Kalfon P
Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Candida dubliniensis fungemia at a large teaching hospital.
Jabra-Rizk MA; Johnson JK; Forrest G; Mankes K; Meiller TF; Venezia RA
Clin Infect Dis; 2005 Oct; 41(7):1064-7. PubMed ID: 16142677
[TBL] [Abstract][Full Text] [Related]
11. The fluconazole era: management of hematogenously disseminated candidiasis in the nonneutropenic patient.
Kramer KM; Skaar DJ; Ackerman BH
Pharmacotherapy; 1997; 17(3):538-48. PubMed ID: 9165556
[TBL] [Abstract][Full Text] [Related]
12. Candidemia in the critically ill patient.
Picazo JJ; González-Romo F; Candel FJ
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S83-5. PubMed ID: 19013345
[TBL] [Abstract][Full Text] [Related]
13. [Candidemia: a never ceasing challenge].
Muñoz García de Paredes P
Rev Clin Esp; 1997 Dec; 197(12):795-7. PubMed ID: 9477668
[No Abstract] [Full Text] [Related]
14. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
[TBL] [Abstract][Full Text] [Related]
15. [Retrospective evaluation of the cases with Candida famata fungemia in a burn unit].
Turunç T; Demiroğlu YZ; Alişkan H; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2009 Jan; 43(1):71-6. PubMed ID: 19334382
[TBL] [Abstract][Full Text] [Related]
16. Candidemia in patients with acute leukemia.
Megalakaki C; Perlorentzou S; Dadakaridou M; Dima I; Repousis P; Mitsouli-Mentzikof C
J BUON; 2006; 11(2):191-5. PubMed ID: 17318970
[TBL] [Abstract][Full Text] [Related]
17. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
18. Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections?
Viale P; Petrosillo N; Signorini L; Puoti M; Carosi G
Clin Infect Dis; 2001 Dec; 33(11):1947-8; author reply 1949-51. PubMed ID: 11692310
[No Abstract] [Full Text] [Related]
19. Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Solomkin JS
New Horiz; 1993 May; 1(2):202-13. PubMed ID: 7922404
[TBL] [Abstract][Full Text] [Related]
20. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
Dimopoulos G; Ntziora F; Rachiotis G; Armaganidis A; Falagas ME
Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
